-
-
-
-
-
-
-
Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026
-
-
-
-
-
-
-
Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC
-
-
-
-
-
-
-
Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders
-
-
-
-
-
-
-
Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders
-
-
-
-
-
-
-
Quanterix Corp. (QTRX) PT Lowered to $15 at Canaccord Genuity
-
-
-
-
-
-
-
Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition
-
-
-
-
-
-
-
Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers
-
1,160,269 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

